NORTHWEST BIOTHERAPEUTICS INC Quarterly Depreciation in USD from Q3 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Northwest Biotherapeutics Inc quarterly/annual Depreciation history and growth rate from Q3 2014 to Q1 2024.
  • Northwest Biotherapeutics Inc Depreciation for the quarter ending March 31, 2024 was $400K, a 33.3% increase year-over-year.
  • Northwest Biotherapeutics Inc annual Depreciation for 2023 was $1.5M, a 15.4% increase from 2022.
  • Northwest Biotherapeutics Inc annual Depreciation for 2022 was $1.3M, a 333% increase from 2021.
  • Northwest Biotherapeutics Inc annual Depreciation for 2021 was $300K, a 245% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $400K +$100K +33.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q1 2023 $300K +$200K +200% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $100K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2020 $87K $54K +$49K +980% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $38K $17K +$9K +113% Jul 1, 2020 Sep 30, 2020 10-Q 2021-01-15
Q2 2020 $29K $2K -$4K -66.7% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $33K $14K +$12K +600% Jan 1, 2020 Mar 31, 2020 10-Q 2020-06-24
Q4 2019 $21K $5K -$232K -97.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $253K $8K -$333K -97.7% Jul 1, 2019 Sep 30, 2019 10-Q 2021-01-15
Q2 2019 $586K $6K -$351K -98.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $937K $2K -$363K -99.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-24
Q4 2018 $1.3M $237K -$22K -8.49% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $1.32M $341K +$300K +732% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.02M $357K +$313K +711% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $709K $365K +$309K +552% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $400K $259K +$205K +380% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-02
Q3 2017 $195K $41K -$14K -25.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 $209K $44K -$23K -34.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $232K $56K +$43K +331% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-16
Q4 2016 $189K $54K +$42K +350% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 $147K $55K +$26K +89.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 $121K $67K +$55K +458% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $66K $13K +$10K +333% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $56K $12K Oct 1, 2015 Dec 31, 2015 10-K 2017-04-17
Q3 2015 $29K -$317K -91.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $12K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $3K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q3 2014 $346K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.